Back to search
FDAFDA · Food and drugs·Recall number D-0260-2025

Bimatoprost NDC# 82187-1001-1 Container description: The product packed in double self-seal cover and finally packed in Aluminum cover for shipping.

Published March 19, 2025 · Recall initiated: February 7, 2025

Summary

FDA records drug Class II recall D-0260-2025, published March 19, 2025 and initiated February 7, 2025. Recalling firm: Aspen Biopharma Labs Pvt., Ltd.; Status: Ongoing; Reported quantity: 400.0 gm; Lot: Lot Numbers: HABTC0020123, exp. date Dec-2026 HABTC0050623, exp. date May-2027 HABTC0091023, exp. date Sep-2028. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Aspen Biopharma Labs Pvt., Ltd.
Distributor
Product was distributed to 3 distributors (1 Hong Kong and 2 accounts in Florida)
Lot
Lot Numbers: HABTC0020123, exp. date Dec-2026 HABTC0050623, exp. date May-2027 HABTC0091023, exp. date Sep-2028
Risk classification
Class II
Area (FDA)
drug
Country
India

Related recalls

Questions about this recall

Was Bimatoprost NDC# 82187-1001-1 Container description: The product packed in double self-seal cover and finally packed in Aluminum cover for shipping. recalled?

Yes. FDA published recall D-0260-2025 on March 19, 2025. Reported hazard: CGMP Deviations

What should I do if I have this product?

Voluntary: Firm initiated · Letter